Addus HomeCare (NASDAQ:ADUS) EVP David Tucker Sells 14,850 Shares of Company Stock

Addus HomeCare Corporation (NASDAQ:ADUS – Get Free Report) EVP David Tucker sold 14,850 shares of the company’s stock in a transaction dated Friday, November 6th. The shares were sold at an average price of $124.75, for a total value of $1,852,537.50. Following the completion of the sale, the executive vice president owned 8,073 shares of the company’s stock, valued at $1,007,106.75. This represents a 64.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Addus HomeCare Trading Up 3.2%

Shares of NASDAQ:ADUS traded up $3.87 during mid-day trading on Tuesday, reaching $126.29. The stock had a trading volume of 225,844 shares, compared to its average volume of 237,872. The firm has a market cap of $2.36 billion, a PE ratio of 21.05, a price-to-earnings-growth ratio of 1.82 and a beta of 0.75. The firm has a 50 day simple moving average of $117.74 and a two-hundred day simple moving average of $106.95. The company has a current ratio of 1.64, a quick ratio of 1.69 and a debt-to-equity ratio of 0.02. Addus HomeCare Corporation has a twelve month low of $87.95 and a twelve month high of $131.59.

Addus HomeCare (NASDAQ:ADUS – Get Free Report) last posted its earnings results on Tuesday, November 3rd. The company reported $1.83 earnings per share for the quarter, topping the consensus estimate of $1.79 by $0.04. The company had revenue of $387.74 million for the quarter, compared to analyst estimates of $388.72 million. Addus HomeCare had a net margin of 7.39% and a return on equity of 10.22%. The business’s revenue for the quarter was up 7.0% compared to the same quarter last year. During the same period last year, the business posted $1.56 earnings per share. On average, research analysts predict that Addus HomeCare Corporation will post 6.34 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

ADUS has been the topic of several recent research reports. Barclays lifted their price target on Addus HomeCare from $96.00 to $101.00 and gave the company an “underweight” rating in a research note on Wednesday, November 4th. UBS Group increased their price objective on Addus HomeCare from $145.00 to $160.00 and gave the stock a “buy” rating in a report on Thursday, November 5th. TD Cowen lifted their target price on Addus HomeCare from $131.00 to $145.00 and gave the company a “buy” rating in a research report on Thursday, November 5th. Raymond James Financial set a $137.00 target price on Addus HomeCare in a research note on Monday, September 28th. Finally, Weiss Ratings raised Addus HomeCare from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday, September 24th. Seven equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $134.70.

Get Our Latest Stock Analysis on Addus HomeCare

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Hsbc Holdings PLC lifted its position in Addus HomeCare by 73.3% during the 2nd quarter. Hsbc Holdings PLC now owns 24,463 shares of the company’s stock worth $2,446,000 after buying an additional 10,350 shares in the last quarter. Summit Creek Advisors LLC acquired a new position in shares of Addus HomeCare during the 2nd quarter worth about $8,552,000. Bank of America Corp DE boosted its stake in shares of Addus HomeCare by 11.3% during the 1st quarter. Bank of America Corp DE now owns 323,037 shares of the company’s stock worth $30,252,000 after buying an additional 32,714 shares during the last quarter. Globeflex Capital L P bought a new position in shares of Addus HomeCare in the 2nd quarter valued at about $1,635,000. Finally, The Manufacturers Life Insurance Company bought a new position in shares of Addus HomeCare in the 2nd quarter valued at about $901,000. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation provides home-based care services to older adults and people with disabilities. Its services are designed to help clients receive care at home and in other community-based settings. The company operates through personal care, hospice and home health services. Personal care includes assistance with daily activities; hospice provides end-of-life care and support; and home health offers skilled nursing and therapy services. Founded in 1979, Addus serves communities across multiple states.

See Also

Insider Buying and Selling by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.